CCNE2 Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O96020 |
---|---|
Clone Names | 100430161 |
Gene ID | 9134 |
---|---|
Other Names | G1/S-specific cyclin-E2, CCNE2 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | CCNE2 |
---|---|
Function | Essential for the control of the cell cycle at the late G1 and early S phase. |
Cellular Location | Nucleus. |
Tissue Location | According to PubMed:9858585, highest levels of expression in adult testis, thymus and brain. Lower levels in placenta, spleen and colon. Consistently elevated levels in tumor-derived cells compared to non-transformed proliferating cells. According to PubMed:9840927: low levels in thymus, prostate, brain, skeletal muscle, and kidney. Elevated levels in lung. According to PubMed:9840943 highly expressed in testis, placenta, thymus and brain. In a lesser extent in small intestine and colon |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene belongs to the highlyconserved cyclin family, whose members are characterized by adramatic periodicity in protein abundance through the cell cycle.Cyclins function as regulators of CDK kinases. Different cyclinsexhibit distinct expression and degradation patterns whichcontribute to the temporal coordination of each mitotic event. Thiscyclin forms a complex with and functions as a regulatory subunitof CDK2. This cyclin has been shown to specifically interact withCIP/KIP family of CDK inhibitors, and plays a role in cell cycleG1/S transition. The expression of this gene peaks at the G1-Sphase and exhibits a pattern of tissue specificity distinct fromthat of cyclin E1. A significantly increased expression level ofthis gene was observed in tumor-derived cells. [provided byRefSeq].
References
Cunningham, J.M., et al. Br. J. Cancer 101(8):1461-1468(2009)Dapas, B., et al. Mol. Med. 15 (9-10), 297-306 (2009) :Caldon, C.E., et al. Mol. Cell. Biol. 29(17):4623-4639(2009)Masamha, C.P., et al. Cancer Res. 69(16):6565-6572(2009)Wu, Z., et al. Neoplasia 11(1):66-76(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.